Clinics I work with
Selected research
-
Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Phase II Multicenter Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
-
Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling.
Nature communications
-
Quantification of cerebrospinal fluid tumor DNA in lung cancer patients with suspected leptomeningeal carcinomatosis.
NPJ precision oncology
Contact me
- Request appointment
- Refer a patient
- (415) 885-3882